Treatment with inebilizumab was associated with continued improvement in patients with AChR+ generalized myasthenia gravis, according to 52-week results from the MINT trial.

CagriSema is a fixed-dose combination of cagrilintide, a long-acting amylin analogue, and semaglutide, a glucagon-like peptide-1 receptor agonist.

A further $50bn of fundraising is also in train, as venture capitalists work on a series of major deals involving OpenAI, Safe Superintelligence and defence tech start-up Anduril. The fervour over AI ...

Anduril Industries’ U.K. unit has signed a nearly 30 million pound ($39 million) deal with the British government to supply ...

Officials from around 20 largely European and Commonwealth countries took part in the latest talks about a peacekeeping ...

The agreement with Anduril will see cutting-edge Altius 600m and Altius 700m systems supplied to Kyiv, the Ministry of ...

Anduril Industries, a controversial California-based defense startup, is trying to hire engineering talent in Boston, but you ...

The United States Air Force (USAF) has announced that Anduril and General Atomics Aeronautical Systems ... land and naval domains 2 free stories per week Daily news round-up email service Access to ...

(via REUTERS)(HT_PRINT) US President Donald Trump is set to ... The company has committed to producing 2-nanometer chips at its second Arizona fab, starting in 2028. It has also agreed to deploy ...

The Defense Department has selected Anduril Industries’ Barracuda-500 cruise missile for testing as part of the next phase of a prototype project. The project “aims to create a highly-producible, ...

Anduril and Zone 5 Technologies have been picked to move to the next... Anduril, Zone 5 Picked To Advance For Cheap Cruise Missile Effort is published in Aerospace Daily & Defense Report ...